Stocktwits on MSN
TSLA stock climbs overnight: ‘SPAC king’ Chamath Palihapitiya sees ‘obvious’ logic in Tesla-SpaceX merger
The investor said a combined company could use one balance sheet and capital structure to fund Elon Musk’s broader ambitions.
Stay updated with the Dr Reddys Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...
Analysts say PNJ faces 'significant' reputational risk from the case involving the former director of its gem certification ...
The market is expected to remain in a consolidation phase in the short term until geopolitical tensions ease and oil prices ...
The company has increased R&D investments and appointed new brand ambassadors while navigating rising input costs and ...
Indian pharma is entering its next growth phase as a new segment gains traction. We analyse four companies building this ...
Healthpeak Properties is set to release its second-quarter results in August, with analysts forecasting single-digit decline in earnings.
Shares of the aerospace name are near the historically bullish 200-day moving average Shares of Rocket Lab Corp (NASDAQ:RKLB) ...
Korean Travel Agencies Stocks Plummet Despite Tourist Surge Hanatour, Modetour Network profits drop as reliance on outbound ...
An AI bubble scare is cracking AI memory stocks, yet big money keeps quietly buying the dip. Is the rally over, or just ...
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
Abbott Laboratories (NYSE: ABT) and Pfizer (NYSE: PFE) both delivered Q1 2026 beats, yet the market treats them differently.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results